483 University Of Texas MD Anderson Cancer Center Mar 2018

483 University Of Texas MD Anderson Cancer Center Mar 2018

Leighton Ngai FDA$119.00 - Available Now

FDA investigators audited the University Of Texas MD Anderson Cancer Center - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 20 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Mar 2018
  • Location: Houston, United States
  • FEI: 3008927689
Add To Cart